Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Randomized Experiments01:13

Randomized Experiments

8.8K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
8.8K
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

360
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
360
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

226
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
226
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

179
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
179
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

406
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
406
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

881
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
881

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Safety-Driven Response Adaptive Randomization: An Application in Noninferiority Oncology Trials.

Statistics in medicine·2026
Same author

Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertension.

Science translational medicine·2026
Same author

A burn-in(g) question: How long should an initial equal randomization stage be before Bayesian response-adaptive randomization?

Statistical methods in medical research·2026
Same author

Endoglin as a BMP9 co-receptor in vascular endothelial cells: prodomain displacement and TGFBRII recruitment.

Nature communications·2025
Same author

BMP9 knockout impairs pulmonary vessel muscularisation and confers aberrant tamoxifen sensitivity.

Angiogenesis·2025
Same author

Drug Development for Pulmonary Arterial Hypertension: Unleashing the Potential of Single-Patient Studies Using Continuous Monitoring.

Pulmonary circulation·2025

相关实验视频

Updated: Jan 15, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

在分层的罕见疾病试验中实施响应适应性随机化:设计挑战和实际解决方案.

Rajenki Das1, Nina Deliu1,2, Mark R Toshner3,4

  • 1MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.

Statistical methods in medical research
|October 6, 2025
PubMed
概括

临床试验中的响应适应性随机化 (RAR) 面临着实际挑战. 本研究引入了用于更好地分配小样本的映射策略,并解决了中间分析期间缺失的数据影响.

关键词:
适应性设计 适应性设计适应性随机化适应性随机化实施实施实施实施实施.绘制地图,绘制地图.罕见病是一种罕见的疾病.

更多相关视频

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

602
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.1K

相关实验视频

Last Updated: Jan 15, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K
Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

602
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.1K

科学领域:

  • 临床试验方法论 临床试验方法论
  • 生物统计学 生物统计学
  • 罕见疾病研究 罕见疾病研究

背景情况:

  • 响应适应性随机化 (RAR) 在临床试验中未得到充分利用,尽管它具有潜力.
  • 实际实施的挑战,特别是在小样本规模和罕见疾病中,往往被忽视.
  • 现有的技术文献经常忽视现实世界试验的复杂性.

研究的目的:

  • 解决在临床试验中实施响应适应性随机化 (RAR) 的实际挑战.
  • 确保RAR分配既可接受又统计准确,特别是在小样本中.
  • 在处理缺少数据时,在临时分析后确定适当的调整.

主要方法:

  • 提出了一种"映射"策略,将随机化概率分离为改善频率错误的分配比率.
  • 分析了在映射策略下缺少数据对操作特征的影响.
  • 研究了诸如数据聚合,盲目评估和安全报告等实际考虑因素.

主要成果:

  • 映射策略提高了RAR分配的可取性,确保它们是可以接受的,并忠于预期的概率,特别是在小样本中.
  • 缺少的数据可能会对操作特征产生重大影响,因此在中间分析时需要仔细考虑.
  • 该研究为解决实际RAR实施问题提供了一个框架.

结论:

  • 映射策略提供了一个可行的解决方案,以改善RAR在小型和罕见疾病试验中的实施.
  • 解决缺失数据对于成功的适应性试验设计至关重要.
  • 为了更广泛地采用RAR,需要进一步研究和讨论诸如遮和安全报告等实际方面.